S1P metabolism in cancer and other pathological conditions

Biochimie

Volumn 92, Issue 6, 2010, Pages 716-723

  Leong, Weng In ^a   Saba, Julie D ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Cancer; Lymphocyte trafficking cancer; Lysophospholipid; S1P lyase; S1P phosphatase; Sphingolipid; Sphingosine 1 phosphate; Sphingosine kinase; Sphingosine phosphate lyase; Tumorigenesis

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; BML 248; DIMETHYLSPHINGOSINE; ENZYME INHIBITOR; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; LT 1002; LT 1009; MONOCLONAL ANTIBODY; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOCRINE EFFECT; AUTOPHAGY; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CATABOLISM; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CIRCULATION; CLINICAL TRIAL; DRUG RECEPTOR BINDING; HUMAN; HYPOXIA; LIPID METABOLISM; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHATIC SYSTEM; LYMPHOCYTE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LYSOPHOSPHOLIPIDS; NEOPLASMS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

EID: 77953289068     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.02.014     Document Type: Review

References (117)

1. Rosen H., Goetzl E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 2005, 5:560-570.
2. Alvarez S.E., Milstien S., Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 2007, 18:300-307.
3. Lee M.J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., Spiegel S., Hla T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998, 279:1552-1555.
4. Van Brocklyn J.R., Lee M.J., Menzeleev R., Olivera A., Edsall L., Cuvillier O., Thomas D.M., Coopman P.J., Thangada S., Liu C.H., Hla T., Spiegel S. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell. Sci. 1998, 142:229-240.
5. Zhang H., Desai N.N., Olivera A., Seki T., Brooker G., Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 1991, 114:155-167.
6. Payne S.G., Milstien S., Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett. 2002, 531:54-57.
7. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
8. Ader I., Malavaud B., Cuvillier O. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Res. 2009, 69:3723-3726.
9. Maceyka M., Payne S.G., Milstien S., Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 2002, 1585:193-201.
10. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 2004, 15:513-520.
11. Taha T.A., Hannun Y.A., Obeid L.M. Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 2006, 39:113-131.
12. Saba J.D., Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res. 2004, 94:724-734.
13. Xia P., Gamble J.R., Wang L., Pitson S.M., Moretti P.A., Wattenberg B.W., D'Andrea R.J., Vadas M.A. An oncogenic role of sphingosine kinase. Curr. Biol. 2000, 10:1527-1530.
14. French K.J., Schrecengost R.S., Lee B.D., Zhuang Y., Smith S.N., Eberly J.L., Yun J.K., Smith C.D. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 2003, 63:5962-5969.
15. Johnson K.R., Johnson K.Y., Crellin H.G., Ogretmen B., Boylan A.M., Harley R.A., Obeid L.M. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J. Histochem. Cytochem. 2005, 53:1159-1166.
16. Kawamori T., Kaneshiro T., Okumura M., Maalouf S., Uflacker A., Bielawski J., Hannun Y.A., Obeid L.M. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2009, 23:405-414.
17. Van Brocklyn J.R., Jackson C.A., Pearl D.K., Kotur M.S., Snyder P.J., Prior T.W. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 2005, 64:695-705.
18. Ruckhaberle E., Rody A., Engels K., Gaetje R., von Minckwitz G., Schiffmann S., Grosch S., Geisslinger G., Holtrich U., Karn T., Kaufmann M. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 2008, 112:41-52.
19. Le Scolan E., Pchejetski D., Banno Y., Denis N., Mayeux P., Vainchenker W., Levade T., Moreau-Gachelin F. Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 2005, 106:1808-1816.
20. Chalfant C.E., Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 2005, 118:4605-4612.
21. Tilly J.L., Kolesnick R.N. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim. Biophys. Acta 2002, 1585:135-138.
22. Xu Y., Xiao Y.J., Baudhuin L.M., Schwartz B.M. The role and clinical applications of bioactive lysolipids in ovarian cancer. J. Soc. Gynecol. Investig. 2001, 8:1-13.
23. Oskouian B., Saba J. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again. Cell Cycle 2007, 6:522-527.
24. Oskouian B., Sooriyakumaran P., Borowsky A.D., Crans A., Dillard-Telm L., Tam Y.Y., Bandhuvula P., Saba J.D. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc. Natl. Acad. Sci. U S A 2006, 103:17384-17389.
25. Lawlor E.R., Soucek L., Brown-Swigart L., Shchors K., Bialucha C.U., Evan G.I. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res. 2006, 66:4591-4601.
26. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33:49-54.
27. Hibbs K., Skubitz K.M., Pambuccian S.E., Casey R.C., Burleson K.M., Oegema T.R., Thiele J.J., Grindle S.M., Bliss R.L., Skubitz A.P. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am. J. Pathol. 2004, 165:397-414.
28. Bernardini M., Lee C.H., Beheshti B., Prasad M., Albert M., Marrano P., Begley H., Shaw P., Covens A., Murphy J., Rosen B., Minkin S., Squire J.A., Macgregor P.F. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 2005, 7:603-613.
29. Visentin B., Vekich J.A., Sibbald B.J., Cavalli A.L., Moreno K.M., Matteo R.G., Garland W.A., Lu Y., Yu S., Hall H.S., Kundra V., Mills G.B., Sabbadini R.A. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 2006, 9:225-238.
30. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
31. Olivera A., Rosenfeldt H.M., Bektas M., Wang F., Ishii I., Chun J., Milstien S., Spiegel S. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J. Biol. Chem. 2003, 278:46452-46460.
32. Van Brocklyn J., Letterle C., Snyder P., Prior T. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett. 2002, 181:195-204.
33. Li Q.F., Wu C.T., Guo Q., Wang H., Wang L.S. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. Biochem. Biophys. Res. Commun. 2008, 371:159-162.
34. + and cell death in prostate cancer cell lines. Auton. Autacoid. Pharmacol. 2007, 27:173-179.
35. Li M.H., Sanchez T., Pappalardo A., Lynch K.R., Hla T., Ferrer F. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol. Cancer Res. 2008, 6:1649-1656.
36. Kohno M., Momoi M., Oo M.L., Paik J.H., Lee Y.M., Venkataraman K., Ai Y., Ristimaki A.P., Fyrst H., Sano H., Rosenberg D., Saba J.D., Proia R.L., Hla T. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell Biol. 2006, 26:7211-7223.
37. Ghosh T.K., Bian J., Gill D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 1990, 248:1653-1656.
38. Desai N.N., Zhang H., Olivera A., Mattie M.E., Spiegel S. Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation. J. Biol. Chem. 1992, 267:23122-23128.
39. Wang F., Nobes C.D., Hall A., Spiegel S. Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts. Biochem. J. 1997, 324(Pt 2):481-488.
40. Cuvillier O., Levade T. Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 2001, 98:2828-2836.
41. Betito S., Cuvillier O. Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. Biochem. Biophys. Res. Commun. 2006, 340:1273-1277.
42. Chang C.L., Ho M.C., Lee P.H., Hsu C.Y., Huang W.P., Lee H. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. Am. J. Physiol. Cell. Physiol. 2009, 297:C451-C458.
43. Lavieu G., Scarlatti F., Sala G., Carpentier S., Levade T., Ghidoni R., Botti J., Codogno P. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 2006, 281:8518-8527.
44. Shida D., Takabe K., Kapitonov D., Milstien S., Spiegel S. Targeting Sphk1 as a new strategy against cancer. Curr. Drug Targets 2008, 9:662-673.
45. Akao Y., Banno Y., Nakagawa Y., Hasegawa N., Kim T.J., Murate T., Igarashi Y., Nozawa Y. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem. Biophys. Res. Commun. 2006, 342:1284-1290.
46. Pchejetski D., Golzio M., Bonhoure E., Calvet C., Doumerc N., Garcia V., Mazerolles C., Rischmann P., Teissie J., Malavaud B., Cuvillier O. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 2005, 65:11667-11675.
47. Nava V.E., Hobson J.P., Murthy S., Milstien S., Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell Res. 2002, 281:115-127.
48. Taha T.A., Kitatani K., El-Alwani M., Bielawski J., Hannun Y.A., Obeid L.M. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J. 2006, 20:482-484.
49. Takabe K., Paugh S.W., Milstien S., Spiegel S. " Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 2008, 60:181-195.
50. Sarkar S., Maceyka M., Hait N.C., Paugh S.W., Sankala H., Milstien S., Spiegel S. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 2005, 579:5313-5317.
51. Sukocheva O.A., Wang L., Albanese N., Pitson S.M., Vadas M.A., Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol. Endocrinol. 2003, 17:2002-2012.
52. Johnson K.R., Johnson K.Y., Becker K.P., Bielawski J., Mao C., Obeid L.M. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J. Biol. Chem. 2003, 278:34541-34547.
53. Bonhoure E., Pchejetski D., Aouali N., Morjani H., Levade T., Kohama T., Cuvillier O. Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 2006, 20:95-102.
54. Kleuser B., Cuvillier O., Spiegel S. 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. 1998, 58:1817-1824.
55. Misasi R., Sorice M., Di Marzio L., Campana W.M., Molinari S., Cifone M.G., Pavan A., Pontieri G.M., O'Brien J.S. Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase. FASEB J. 2001, 15:467-474.
56. Edsall L.C., Cuvillier O., Twitty S., Spiegel S., Milstien S. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 2001, 76:1573-1584.
57. Bektas M., Jolly P.S., Muller C., Eberle J., Spiegel S., Geilen C.C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 2005, 24:178-187.
58. Shu X., Wu W., Mosteller R.D., Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 2002, 22:7758-7768.
59. Weigert A., Schiffmann S., Sekar D., Ley S., Menrad H., Werno C., Grosch S., Geisslinger G., Brune B. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. Int. J. Cancer 2009, 125:2114-2121.
60. Li G., Alexander H., Schneider N., Alexander S. Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium. Microbiol. 2000, 146(Pt 9):2219-2227.
61. Min J., Stegner A.L., Alexander H., Alexander S. Overexpression of sphingosine-1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum-based chemotherapy drugs. Eukaryot .Cell 2004, 3:795-805.
62. Min J., Van Veldhoven P.P., Zhang L., Hanigan M.H., Alexander H., Alexander S. Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol. Cancer Res. 2005, 3:287-296.
63. Young N., Pearl D.K., Van Brocklyn J.R. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol. Cancer Res. 2009, 7:23-32.
64. Van Brocklyn J.R., Young N., Roof R. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett. 2003, 199:53-60.
65. 2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res. 2005, 65:3788-3795.
66. Bryan L., Paugh B.S., Kapitonov D., Wilczynska K.M., Alvarez S.M., Singh S.K., Milstien S., Spiegel S., Kordula T. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Mol. Cancer Res. 2008, 6:1469-1477.
67. 2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem. 2003, 278:32841-32851.
68. Yamaguchi H., Kitayama J., Takuwa N., Arikawa K., Inoki I., Takehara K., Nagawa H., Takuwa Y. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 2003, 374:715-722.
69. Bergelin N., Blom T., Heikkila J., Lof C., Alam C., Balthasar S., Slotte J.P., Hinkkanen A., Tornquist K. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. Endocrinology 2009, 150:2055-2063.
70. Yamashita H., Kitayama J., Shida D., Yamaguchi H., Mori K., Osada M., Aoki S., Yatomi Y., Takuwa Y., Nagawa H. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. J. Surg. Res. 2006, 130:80-87.
71. 1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer Lett. 2009, 276:171-179.
72. Park K.S., Kim M.K., Lee H.Y., Kim S.D., Lee S.Y., Kim J.M., Ryu S.H., Bae Y.S. S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. Biochem. Biophys. Res. Commun. 2007, 356:239-244.
73. Guo X.Z., Zhang W.W., Wang L.S., Lu Z.Z., Wang H., Xu J.H., Tian H. Adenovirus-mediated overexpression of KAI1 suppresses sphingosine kinase activation and metastasis of pancreatic carcinoma cells. Zhonghua Nei Ke Za Zhi 2006, 45:752-754.
74. Hait N.C., Sarkar S., Le Stunff H., Mikami A., Maceyka M., Milstien S., Spiegel S. Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J. Biol. Chem. 2005, 280:29462-29469.
75. Hait N.C., Bellamy A., Milstien S., Kordula T., Spiegel S. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 2007, 282:12058-12065.
76. Argraves K.M., Wilkerson B.A., Argraves W.S., Fleming P.A., Obeid L.M., Drake C.J. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J. Biol. Chem. 2004, 279:50580-50590.
77. Chae S.S., Paik J.H., Furneaux H., Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J. Clin. Invest. 2004, 114:1082-1089.
78. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell Biol. 2005, 25:11113-11121.
79. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 2000, 106:951-961.
80. Xia P., Wang L., Gamble J.R., Vadas M.A. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 1999, 274:34499-34505.
81. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 2001, 276:7614-7620.
82. 1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc. Natl. Acad. Sci. U S A 2003, 100:10664-10669.
83. 3 (EDG3). Blood 2003, 102:2099-2107.
84. Okamoto H., Takuwa N., Yokomizo T., Sugimoto N., Sakurada S., Shigematsu H., Takuwa Y. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell Biol. 2000, 20:9247-9261.
85. Kluk M.J., Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta 2002, 1582:72-80.
86. Sounni N.E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., Deroanne C., Thompson E.W., Foidart J.M., Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002, 16:555-564.
87. Langlois S., Gingras D., Beliveau R. Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 2004, 103:3020-3028.
88. Vaupel P., Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis. Rev. 2007, 26:225-239.
89. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
90. Ader I., Brizuela L., Bouquerel P., Malavaud B., Cuvillier O. Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. Cancer Res. 2008, 68:8635-8642.
91. Anelli V., Gault C.R., Cheng A.B., Obeid L.M. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J. Biol. Chem. 2008, 283:3365-3375.
92. Skoura A., Sanchez T., Claffey K., Mandala S.M., Proia R.L., Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J. Clin. Invest. 2007, 117:2506-2516.
93. Schnitzer S.E., Weigert A., Zhou J., Brune B. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol. Cancer Res. 2009, 7:393-401.
94. Azuma H., Takahara S., Horie S., Muto S., Otsuki Y., Katsuoka Y. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J. Urol. 2003, 169:2372-2377.
95. Lee T.K., Man K., Ho J.W., Wang X.H., Poon R.T., Xu Y., Ng K.T., Chu A.C., Sun C.K., Ng I.O., Sun H.C., Tang Z.Y., Xu R., Fan S.T. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin. Cancer Res. 2005, 11:8458-8466.
96. Salinas N.R., Lopes C.T., Palma P.V., Oshima C.T., Bueno V. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720. Pathol. Oncol. Res. 2009.
97. Salinas N.R., Oshima C.T., Cury P.M., Cordeiro J.A., Bueno V. FTY720 and lung tumor development. Int. Immunopharmacol. 2009, 9:689-693.
98. Azuma H., Horie S., Muto S., Otsuki Y., Matsumoto K., Morimoto J., Gotoh R., Okuyama A., Suzuki S., Katsuoka Y., Takahara S. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res. 2003, 23:3183-3193.
99. LaMontagne K., Littlewood-Evans A., Schnell C., O'Reilly T., Wyder L., Sanchez T., Probst B., Butler J., Wood A., Liau G., Billy E., Theuer A., Hla T., Wood J. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res. 2006, 66:221-231.
100. Balthasar S., Samulin J., Ahlgren H., Bergelin N., Lundqvist M., Toescu E.C., Eggo M.C., Tornquist K. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Biochem. J. 2006, 398:547-556.
101. 1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 2007, 25:115-124.
102. O'Brien N., Jones S.T., Williams D.G., Cunningham H.B., Moreno K., Visentin B., Gentile A., Vekich J., Shestowsky W., Hiraiwa M., Matteo R., Cavalli A., Grotjahn D., Grant M., Hansen G., Campbell M.A., Sabbadini R. Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J. Lipid. Res. 2009.
103. Endo K., Igarashi Y., Nisar M., Zhou Q.H., Hakomori S. Cell membrane signaling as target in cancer therapy: inhibitory effect of N, N-dimethyl and N, N, N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. 1991, 51:1613-1618.
104. Okoshi H., Hakomori S., Nisar M., Zhou Q.H., Kimura S., Tashiro K., Igarashi Y. Cell membrane signaling as target in cancer therapy. II: inhibitory effect of N, N, N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Cancer Res. 1991, 51:6019-6024.
105. Paugh S.W., Paugh B.S., Rahmani M., Kapitonov D., Almenara J.A., Kordula T., Milstien S., Adams J.K., Zipkin R.E., Grant S., Spiegel S. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 2008, 112:1382-1391.
106. French K.J., Upson J.J., Keller S.N., Zhuang Y., Yun J.K., Smith C.D. Antitumor activity of sphingosine kinase inhibitors. J. Pharmacol. Exp. Ther. 2006, 318:596-603.
107. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
108. Bandhuvula P., Tam Y.Y., Oskouian B., Saba J.D. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 2005, 280:33697-33700.
109. Schwab S.R., Pereira J.P., Matloubian M., Xu Y., Huang Y., Cyster J.G. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005, 309:1735-1739.
110. Vogel P., Donoviel M.S., Read R., Hansen G.M., Hazlewood J., Anderson S.J., Sun W., Swaffield J., Oravecz T. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 2009, 4:e4112.
111. Katsel P., Li C., Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?. Neurochem. Res. 2007, 32:845-856.
112. He X., Huang Y., Li B., Gong C.X., Schuchman E.H. Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol. Aging. 2008.
113. Morgan A.R., Turic D., Jehu L., Hamilton G., Hollingworth P., Moskvina V., Jones L., Lovestone S., Brayne C., Rubinsztein D.C., Lawlor B., Gill M., O'Donovan M.C., Owen M.J., Williams J. Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:762-770.
114. Venkataraman K., Lee Y.M., Michaud J., Thangada S., Ai Y., Bonkovsky H.L., Parikh N.S., Habrukowich C., Hla T. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res. 2008, 102:669-676.
115. Liu Z.J., Velazquez O.C. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid. Redox. Signal 2008, 10:1869-1882.
116. Kawanabe T., Kawakami T., Yatomi Y., Shimada S., Soma Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J. Dermatol. Sci. 2007, 48:53-60.
117. 2 triggers hepatic wound healing. FASEB J. 2007, 21:2005-2013.